The 18-Month Ban, the Twin, and the TUE Gap: Why India's Doping Data Doesn't Match the Rulebook

The file on my desk this morning carried two numbers sitting side by side: 18 and 4. A 17-year-old Indian swimmer has been handed an 18-month suspension; the standard penalty for a doping rule violation is four years. The gap between those two figures lives in no data table. It lives in the word “intent” — something no sensor under the water can reach.

And behind the case sits a detail that made me reopen three old data files: the suspended swimmer's twin brother remains on India's roster for the upcoming Asian Games. Two people, nearly the same name, both of whom have represented the country at international junior meets. Result sheets have repeatedly confused the two brothers, making it nearly impossible to isolate one athlete's results from the other's.

In my line of work, a data pair that cannot be separated is a data pair that is useless.

Context: February, terbutaline, and a declaration form

The swimmer tested positive in February. The Swimming Federation of India withdrew his name from the Commonwealth Games roster, and later from the Asian Games roster. The substance detected was terbutaline — a beta-2 agonist that, according to the Mayo Clinic, is commonly prescribed for patients with asthma, emphysema, bronchitis, and other lung diseases.

According to the Times of India, the swimmer suffered from smoke inhalation and took the prescription with a doctor's approval, but did not properly obtain a therapeutic use exemption (TUE). He listed the substance on his doping control form.

This is where I stop and look twice. In doping files, an athlete voluntarily declaring a banned substance on a control form is rare behaviour. It does not prove innocence, but it is a behavioural signal my model classifies as “low intentional risk”. Athletes who deliberately cheat rarely point the finger at themselves before their urine sample is analysed.

An expedited hearing took place last week. India's national swimming federation hoped the case would be dropped so he could race in Japan this month. He had qualified for two events. The final outcome: 18 months. His Asian season ended before it began.

The penalty framework and its three reduction tiers

I have sat through enough hearings to know that doping sanctions are not decided by a single number. The standard framework is four years. It can drop to two if the panel believes the athlete did not intentionally dope. And it can drop further still, depending on how persuasive the explanation is.

Those three tiers produce an outcome my profession calls “soft-evidence inflation”. The same substance, the same concentration, two athletes in two countries, two different penalties. Not because their biological profiles differ, but because the quality of their lawyers, their medical records, and their paperwork differs.

With terbutaline, the real question is not “was there a banned substance in the sample”. The real question is: “Why was the therapeutic use exemption not filed on time?”

I do not trust emotion. I trust a data series longer than your emotion. And the series here shows that smaller federations, with thin medical budgets, carry a far higher rate of administrative error in TUE paperwork than large federations. That is a structural asymmetry, and it appears in no penalty table.

India and its place in the doping data table

India is the world's most populous nation, but not a global sporting superpower. At the 2026 Summer Olympic Games, the country won six medals, none of them gold. Yet in anti-doping rule violations, India has led the world for several consecutive years.

Those two facts sitting side by side raise a question I always ask before any rushed conclusion: is this a moral problem, or a control problem?

There is a comparison I keep in a private drawer. A country's absolute violation count depends on three variables: the size of its sporting population, the number of tests conducted, and the testing rate in low-revenue sports. India leads in all three. If a country tests more, it will catch more. That does not make it the most cheating nation; it makes it the most scrutinised one.

I have covered swimming for the Australian market for five years, and in those five years I learned one thing: swimming is a sport where the gap between champion and eliminated is measured in hundredths of a second, but the gap between a clean athlete and a suspended one is measured in paperwork. That is a structural injustice no leaderboard displays.

But I will not stop there, because stopping there is laziness. Based on my experience tracking meets and files, most violations in India cluster among young athletes, low-budget sports, and substances in the ordinary therapeutic drug class. That is the pattern of a sports-medicine system that has not kept pace with the testing system, not necessarily the pattern of an organised doping culture.

The contrarian angle: the twin is the blind spot of the data

This is the part I consider most important, and also the least discussed.

A minor athlete violated the rules, and his identity was not published. That is ethically correct for protecting a child. But when the twin brother still competes, and result sheets repeatedly confuse the two, we have a serious data problem: every performance metric attached to “that name” cannot be attributed to a verifiable individual.

In swimming, where performance is measured in hundredths of a second, a pair of twins with nearly identical names is an identity loophole. Anti-doping systems rely on biometric records and the testing history of each individual. If the competition history is blurred, the testing history risks being blurred too.

I am not saying the other athlete is at fault. I am saying the current data system is not strong enough to separate the two. And a system that cannot separate its data cannot conclude anything.

What to watch in the next cycle

Numbers have no gender, but the people who read them do. An 18-month ban reads like leniency; read closely, it is an administrative failure softened by good faith. The athlete lost the Asian Games not because he used lung medication. He lost it because a TUE form was not filed correctly.

What I will watch at the upcoming Asian Games: whether the twin brother competes, and whether organisers publish results under clear individual identifiers, or continue to let two names blur into one. If they blur, then every performance analysis of this family is analysis built on sand.

Finally, the question I leave behind is not for the 17-year-old. It is for the system that let him step onto the lane with a prescription in hand and an administrative void behind him.

The limits of the data

I must be clear about the territory I cannot reach.

First, the athlete's identity was not published, so any comparison with similar violations is only relative.

Second, his personal medical records are not in my hands. I do not know the actual severity of the smoke inhalation, and that is a variable I cannot quantify.

Third, and most importantly: motive. No metric measures whether a person believed they were doing the right thing. Kazan was the day I learned that a 99% probability can still die on the betting table. My model can compute probability, but probability is not truth, and a 17-year-old athlete is not a variable in a spreadsheet. Experience tells me this: behind every calculation is a human being, and a human being can die even when the probability is 99%.